𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Out-of-pocket payment and cost-effectiveness of XELOX and XELOX plus bevacizumab therapy: from the perspective of metastatic colorectal cancer patients in Japan

✍ Scribed by Takeru Shiroiwa; Takashi Fukuda; Kiichiro Tsutani


Publisher
Springer
Year
2010
Tongue
English
Weight
595 KB
Volume
15
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.